Revision history of "CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability" (Q39642145)

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 September 2023

24 July 2023

11 March 2023

6 October 2022

7 August 2021

2 August 2021

23 April 2021

29 September 2019

3 July 2019

22 January 2019

26 November 2018

22 November 2018

21 August 2018

6 January 2018

14 September 2017

13 September 2017